| Date Filed | Type | Description |
| 06/12/2023 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 05/03/2023 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 3,481 options to buy
@ $342.73, valued at
$1.2M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,900 shares
@ $280.19, valued at
$1.4M
Sold 100 shares
@ $281.49, valued at
$28.1k
Exercised 5,000 options to buy
@ $127.54, valued at
$637.7k
|
|
| 04/04/2022 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,019 shares
@ $261.28, valued at
$266.2k
Sold 2,970 shares
@ $262.37, valued at
$779.2k
Sold 1,011 shares
@ $262.97, valued at
$265.9k
Exercised 5,000 options to buy
@ $127.54, valued at
$637.7k
|
|
| 02/01/2022 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,901 shares
@ $240.53, valued at
$457.2k
Sold 800 shares
@ $241.83, valued at
$193.5k
Sold 2,087 shares
@ $242.78, valued at
$506.7k
Sold 212 shares
@ $243.24, valued at
$51.6k
Exercised 5,000 options to buy
@ $127.54, valued at
$637.7k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 7,700 options to buy
@ $123.12, valued at
$948k
|
|
| 12/09/2020 |
3
| MCGLYNN MARGARET G (Director) has filed a Form 3 on NOVAVAX INC |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Gifted 3,707 shares
@ $0 |
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 5,855 shares
@ $0
Granted 18,574 options to buy
@ $12.81, valued at
$237.9k
|
|
| 06/03/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 699 shares
@ $0
Granted 2,264 options to buy
@ $286.27, valued at
$648.1k
|
|
| 04/20/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $11, valued at
$110k
Exercised 10,000 options to buy
@ $2.81, valued at
$28.1k
|
|
| 04/02/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AIR PRODUCTS & CHEMICALS INC /DE/|
Txns:
| Granted 237 options to buy
@ $206.53, valued at
$48.9k
|
|
| 01/24/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AIR PRODUCTS & CHEMICALS INC /DE/|
Txns:
| Granted 630 options to buy
@ $238.04, valued at
$150k
|
|
| 01/10/2020 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 20,000 shares
@ $10, valued at
$200k
Exercised 20,000 options to buy
@ $3.32, valued at
$66.4k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2019 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AIR PRODUCTS & CHEMICALS INC /DE/|
Txns:
| Granted 3,973 options to buy
@ $0 |
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2019 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10,000 shares
@ $185, valued at
$1.9M
Exercised 10,000 options to buy
@ $81.54, valued at
$815.4k
|
|
| 07/02/2019 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AIR PRODUCTS & CHEMICALS INC /DE/|
Txns:
| Granted 195 options to buy
@ $226.37, valued at
$44k
|
|
|